Drugs / interleukin-12 gene
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00072098 | Sep 2003 → Jan 2012 | metastasis from malignant tumor of colon | Max Sung | Terminated | No outcome recorded Stop: Business |
| Phase 1 | NCT00028652 | Jan 2002 → ? | metastatic malignant neoplasm | University of Wisconsin, Madison | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | interleukin-12 gene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00072098 ↗ |
| Route | Other | “Patients receive interleukin-12 gene intratumorally over 5 minutes on days 1, 3, and 5.” NCT00028652 ↗ |